Novo Nordisk's Wegovy improves kidney health in patients with obesity (NYSE:NVO)
hapabapa/iStock Editorial via Getty Images Novo Nordisk's (NVO) anti-obesity therapy Wegovy reduced kidney-related adverse events by 22% in overweight and ...
Tag: Wegovy
US FDA approves Lilly weight loss drug and will compete with Wegovy de Novo By Reuters
© Reuters. FILE PHOTO: An Eli Lilly and Company pharmaceutical manufacturing facility at 50 ImClone Drive in Branchburg, New Jersey, ...
Novo Nordisk shares fall as Viatris fights Wegovy patents
JHVEPhoto Despite a recent rally, Novo Nordisk (NVO), Europe's second most valuable company, has underperformed in recent weeks as markets ...
Recommended.
